MORE Health launches international access to Japan's health services | Healthcare Asia Magazine
, Japan

MORE Health launches international access to Japan's health services

The partnership with Japan’s Integrity Health will deliver a remote health diagnosis.

Global healthcare company MORE Health and Japan’s Integrity Healthcare (IH) formed a joint venture that will launch a new collaborative diagnosis service platform called Co-Diagnosis.

MORE Health, through its network of tertiary and quaternary Aacademic medical centers and physician specialists, delivers a version of medical second opinion for its patients, called a collaborative diagnosis, or Co-Diagnosis.

International patients will be given access to the top physicians and services of Integrity Healthcare.The service, which is delivered via a full-featured, intuitive and HIPAA-compliant online platform will work in concert with IH’s wide network of medical institutions and renowned specialists providing comprehensive resources for the treatment of cardiovascular diseases and various cancers including gastrointestinal cancer.

Together with the patient's treating physicians in their home country, IH’s physician specialists will team up to deliver a time-saving diagnosis and treatment plan, providing patients with a remote second opinion.

Join Healthcare Asia Magazine community
Since you're here...

...there are many ways you can work with us to advertise your company and connect to your customers. Our team can help you dight and create an advertising campaign, in print and digital, on this website and in print magazine.

We can also organize a real life or digital event for you and find thought leader speakers as well as industry leaders, who could be your potential partners, to join the event. We also run some awards programmes which give you an opportunity to be recognized for your achievements during the year and you can join this as a participant or a sponsor.

Let us help you drive your business forward with a good partnership!

Exclusives

NUHCS to start using breakthrough drug for rare lung condition
Winrevair, which treats hypertension from constricted lung arteries, costs  $3,700-$6,730
Healthcare
Singapore’s aged care homes fall short
Their services are routinary and not personalised mainly due to resource constraints.
Healthcare
Electronic health records with AI show promise
They are also at risk from backdoor attacks, data poisoning and unauthorised access.